Yu XY - Search Results

1

Microfluidics applications for high-throughput single cell sequencing.

Zhou WM, Yan YY, Guo QR, Ji H, Wang H, Xu TT, Makabel B, Pilarsky C, He G, Yu XY, Zhang JY. Zhou WM, et al. Among authors: yu xy. J Nanobiotechnology. 2021 Oct 11;19(1):312. doi: 10.1186/s12951-021-01045-6. J Nanobiotechnology. 2021. PMID: 34635104 Free PMC article. Review.

2

CuS Nanodot-Loaded Thermosensitive Hydrogel for Anticancer Photothermal Therapy.

Fu JJ, Zhang JY, Li SP, Zhang LM, Lin ZX, Liang L, Qin AP, Yu XY. Fu JJ, et al. Among authors: yu xy. Mol Pharm. 2018 Oct 1;15(10):4621-4631. doi: 10.1021/acs.molpharmaceut.8b00624. Epub 2018 Sep 13. Mol Pharm. 2018. PMID: 30179511

3

Preparation, characterization and in vitro-in vivo evaluation of bortezomib supermolecular aggregation nanovehicles.

Chen MY, Xiao ZK, Lei XP, Li JX, Yu XY, Zhang JY, Ye GD, Guo YJ, Mo G, Li CW, Zhang Y, Zhang LM, Lin ZQ, Fu JJ. Chen MY, et al. Among authors: yu xy. J Nanobiotechnology. 2020 Apr 3;18(1):57. doi: 10.1186/s12951-020-00612-7. J Nanobiotechnology. 2020. PMID: 32245495 Free PMC article.

4

Multifunctional microfluidic chip for cancer diagnosis and treatment.

Guo QR, Zhang LL, Liu JF, Li Z, Li JJ, Zhou WM, Wang H, Li JQ, Liu DY, Yu XY, Zhang JY. Guo QR, et al. Among authors: yu xy. Nanotheranostics. 2021 Jan 1;5(1):73-89. doi: 10.7150/ntno.49614. eCollection 2021. Nanotheranostics. 2021. PMID: 33391976 Free PMC article. Review.

5

pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer.

Wang H, Shi W, Zeng D, Huang Q, Xie J, Wen H, Li J, Yu X, Qin L, Zhou Y. Wang H, et al. J Nanobiotechnology. 2021 May 22;19(1):152. doi: 10.1186/s12951-021-00895-4. J Nanobiotechnology. 2021. PMID: 34022909 Free PMC article.

6

The cellular immunotherapy of integrated photothermal anti-oxidation Pd-Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis.

Zheng C, Wu A, Zhai X, Ji H, Chen Z, Chen X, Yu X. Zheng C, et al. Acta Pharm Sin B. 2021 Jul;11(7):1993-2003. doi: 10.1016/j.apsb.2021.02.021. Epub 2021 Mar 4. Acta Pharm Sin B. 2021. PMID: 34386333 Free PMC article.

7

Artificial exosomes mediated spatiotemporal-resolved and targeted delivery of epigenetic inhibitors.

Li H, Li S, Lin Y, Chen S, Yang L, Huang X, Wang H, Yu X, Zhang L. Li H, et al. J Nanobiotechnology. 2021 Nov 17;19(1):364. doi: 10.1186/s12951-021-01107-9. J Nanobiotechnology. 2021. PMID: 34789273 Free PMC article.

8

Biological roles of RNA m⁵C modification and its implications in Cancer immunotherapy.

Song H, Zhang J, Liu B, Xu J, Cai B, Yang H, Straube J, Yu X, Ma T. Song H, et al. Biomark Res. 2022 Apr 1;10(1):15. doi: 10.1186/s40364-022-00362-8. Biomark Res. 2022. PMID: 35365216 Free PMC article. Review.

9

Activatable unsaturated liposomes increase lipid peroxide of cell membrane and inhibit tumor growth.

Fu JJ, Liu CC, Feng GN, Li SP, Yu YY, Du LR, Zhang JY, Zhang Y, Lei XP, Dai X, Yu XY. Fu JJ, et al. Among authors: yu yy, yu xy. Biomater Adv. 2023 Apr;147:213323. doi: 10.1016/j.bioadv.2023.213323. Epub 2023 Feb 2. Biomater Adv. 2023. PMID: 36764198

10

Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy.

Guan X, Xu X, Tao Y, Deng X, He L, Lin Z, Chang J, Huang J, Zhou D, Yu X, Wei M, Zhang L. Guan X, et al. J Nanobiotechnology. 2024 Nov 10;22(1):692. doi: 10.1186/s12951-024-02967-7. J Nanobiotechnology. 2024. PMID: 39523308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

869 results

Search Page

Filters